296 related articles for article (PubMed ID: 33176965)
21. Capsaicin attenuates imiquimod-induced epidermal hyperplasia and cutaneous inflammation in a murine model of psoriasis.
Chan TC; Lee MS; Huang WC; Chang WY; Krueger JG; Tsai TF
Biomed Pharmacother; 2021 Sep; 141():111950. PubMed ID: 34328106
[TBL] [Abstract][Full Text] [Related]
22. Topical administration of nanocarrier miRNA-210 antisense ameliorates imiquimod-induced psoriasis-like dermatitis in mice.
Feng H; Wu R; Zhang S; Kong Y; Liu Z; Wu H; Wang H; Su Y; Zhao M; Lu Q
J Dermatol; 2020 Feb; 47(2):147-154. PubMed ID: 31773789
[TBL] [Abstract][Full Text] [Related]
23. Ginsenoside Rg1 abolish imiquimod-induced psoriasis-like dermatitis in BALB/c mice via downregulating NF-κB signaling pathway.
Shi Q; He Q; Chen W; Long J; Zhang B
J Food Biochem; 2019 Nov; 43(11):e13032. PubMed ID: 31502279
[TBL] [Abstract][Full Text] [Related]
24. Cornuside alleviates psoriasis-like skin lesions in mice by relieving inflammatory effects.
Yan F; Wang L; Zhang J; Liu Z; Yu B; Li W; Guo Z; Shi D; Zhang H; Xiong H
Int Immunopharmacol; 2024 Jun; 134():112183. PubMed ID: 38705031
[TBL] [Abstract][Full Text] [Related]
25. Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis.
Shimizu T; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Dermatol Sci; 2019 Sep; 95(3):90-98. PubMed ID: 31362906
[TBL] [Abstract][Full Text] [Related]
26. Hydroxychloroquine exacerbates imiquimod-induced psoriasis-like dermatitis through stimulating overexpression of IL-6 in keratinocytes.
Yen LJ; Chen YC; Wang KC; Shih MC; Li CL; Yu SJ; Lu LY
Immunopharmacol Immunotoxicol; 2024 Feb; 46(1):128-137. PubMed ID: 38059657
[TBL] [Abstract][Full Text] [Related]
27. Apremilast downregulates interleukin-17 production and induces splenic regulatory B cells and regulatory T cells in imiquimod-induced psoriasiform dermatitis.
Uchida H; Kamata M; Shimizu T; Egawa S; Ito M; Takeshima R; Mizukawa I; Watanabe A; Tada Y
J Dermatol Sci; 2021 Oct; 104(1):55-62. PubMed ID: 34548208
[TBL] [Abstract][Full Text] [Related]
28. Activation of Langerhans cells promotes the inflammation in imiquimod-induced psoriasis-like dermatitis.
Xiao C; Zhu Z; Sun S; Gao J; Fu M; Liu Y; Wang G; Yao X; Li W
J Dermatol Sci; 2017 Mar; 85(3):170-177. PubMed ID: 27964879
[TBL] [Abstract][Full Text] [Related]
29. Decryption of Active Constituents and Action Mechanism of the Traditional Uighur Prescription (BXXTR) Alleviating IMQ-Induced Psoriasis-Like Skin Inflammation in BALB/c Mice.
Pang X; Zhang K; Huang J; Wang H; Gao L; Wang T; Sun Y; Chen L; Wang J
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933541
[TBL] [Abstract][Full Text] [Related]
30. The vitamin D
Hau CS; Shimizu T; Tada Y; Kamata M; Takeoka S; Shibata S; Mitsui A; Asano Y; Sugaya M; Kadono T; Sato S; Watanabe S
J Dermatol Sci; 2018 Nov; 92(2):117-126. PubMed ID: 30166055
[TBL] [Abstract][Full Text] [Related]
31. Terrestrosin D ameliorates skin lesions in an imiquimod-induced psoriasis-like murine model by inhibiting the interaction between Substance P and Dendritic cells.
Guo J; Qi C; Liu Y; Guo X; Meng Y; Zhao J; Fu J; Di T; Zhang L; Guo X; Liu Q; Wang Y; Li P; Wang Y
Phytomedicine; 2022 Jan; 95():153864. PubMed ID: 34923236
[TBL] [Abstract][Full Text] [Related]
32. Regulatory T cells suppress skin inflammation in the imiquimod-induced psoriasis-like mouse model.
Choi CW; Kim BR; Yang S; Kim Y; Kang JS; Youn SW
J Dermatol Sci; 2020 Jun; 98(3):199-202. PubMed ID: 32451152
[No Abstract] [Full Text] [Related]
33. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
[TBL] [Abstract][Full Text] [Related]
34. 2'-fucosyllactose inhibits imiquimod-induced psoriasis in mice by regulating Th17 cell response via the STAT3 signaling pathway.
Lei K; Wang D; Lin L; Zeng J; Li Y; Zhang L; Lane JA; Zuo D; Sun L
Int Immunopharmacol; 2020 Aug; 85():106659. PubMed ID: 32544868
[TBL] [Abstract][Full Text] [Related]
35. Artesunate alleviates imiquimod-induced psoriasis-like dermatitis in BALB/c mice.
Huang ZZ; Xu Y; Xu M; Shi ZR; Mai SZ; Guo ZX; Tang ZQ; Luo YJ; Guo Q; Xiong H
Int Immunopharmacol; 2019 Oct; 75():105817. PubMed ID: 31446161
[TBL] [Abstract][Full Text] [Related]
36. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ
FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852
[TBL] [Abstract][Full Text] [Related]
37. Effects of tumor necrosis factor-like ligand 1A (TL1A) on imiquimod-induced psoriasiform skin inflammation in mice.
Li L; Fu L; Zhou P; Lu Y; Zhang L; Wang W; Nie J; Zhang D; Liu Y; Wu B; Chen T
Arch Dermatol Res; 2020 Sep; 312(7):481-490. PubMed ID: 31953572
[TBL] [Abstract][Full Text] [Related]
38. Topical application of endothelin receptor a antagonist attenuates imiquimod-induced psoriasiform skin inflammation.
Nakahara T; Kido-Nakahara M; Ulzii D; Miake S; Fujishima K; Sakai S; Chiba T; Tsuji G; Furue M
Sci Rep; 2020 Jun; 10(1):9510. PubMed ID: 32528072
[TBL] [Abstract][Full Text] [Related]
39. Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8
Chen Y; Yan Y; Liu H; Qiu F; Liang CL; Zhang Q; Huang RY; Han L; Lu C; Dai Z
Theranostics; 2020; 10(23):10466-10482. PubMed ID: 32929360
[TBL] [Abstract][Full Text] [Related]
40. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
